Results 151 to 160 of about 44,419 (235)

BRCA1/2 Reversion Mutations and Cancer Therapy Resistance. [PDF]

open access: yesBiology (Basel)
Qi W   +6 more
europepmc   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Identification of <i>BRCA2</i> Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas. [PDF]

open access: yesOncol Res
Quoc Tran D   +11 more
europepmc   +1 more source

Protein–protein interactions of Fanconi anemia proteins FANCI, FANCD2 and BRCA2 [PDF]

open access: yesActa Crystallographica Section A Foundations and Advances, 2017
Mohd Quadir Siddiqui   +3 more
openaire   +1 more source

Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study. [PDF]

open access: yesFam Cancer
Grandi G   +20 more
europepmc   +1 more source

Altered Estrogen Receptor Signaling Pathway in BRCA2-Deficient Estrogen Receptor-Positive/HER2-Negative Breast Cancer. [PDF]

open access: yesCancer Rep (Hoboken)
Kawasaki K   +12 more
europepmc   +1 more source

The Brca1 and Brca2 proteins and tumor pathogenesis

open access: yes, 2010
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldGermline alterations of the BRCA1 or BRCA2 genes result in susceptibility to breast and ovarian cancer.
Ingvarsson, S
core  

Clinicopathologic characteristics of early-onset breast cancer among unselected young Black women. [PDF]

open access: yesCancer
Beasley HK   +11 more
europepmc   +1 more source

Comprehensive <i>BRCA1/2</i> mutation landscape in prostate cancer in the UAE and Arab population. [PDF]

open access: yesFront Cell Dev Biol
Al Shareef ZM   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy